Tags

Type your tag names separated by a space and hit enter

Serum zinc, copper and magnesium in sickle cell disease at Ibadan, south western Nigeria.
Afr J Med Med Sci. 1999 Sep-Dec; 28(3-4):137-9.AJ

Abstract

Serum zinc, copper and magnesium were studied in patients with sickle cell disease in the steady state. There was significantly lower serum zinc concentration (P < 0.01) and significantly higher serum copper and magnesium in haemoglobin S patients compared with controls (HbA). In haemoglobin SC patients, there was a significant reduction in serum zinc (P < 0.01) but no significant difference in serum copper and magnesium concentrations compared with the controls. There was no significant difference in serum zinc concentration between the HbS and HbS + C patients. However there were significantly higher serum copper and magnesium in HbS than HbS + C patients (P < 0.01) The level of serum zinc has no correlation with the steady state Haematocrit or severity index score in HbS and HbS + C patients.

Authors+Show Affiliations

Department of Chemical Pathology, University College Hospital, Ibadan, Nigeria.No affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

11205817

Citation

Akenami, F O., et al. "Serum Zinc, Copper and Magnesium in Sickle Cell Disease at Ibadan, South Western Nigeria." African Journal of Medicine and Medical Sciences, vol. 28, no. 3-4, 1999, pp. 137-9.
Akenami FO, Aken'Ova YA, Osifo BO. Serum zinc, copper and magnesium in sickle cell disease at Ibadan, south western Nigeria. Afr J Med Med Sci. 1999;28(3-4):137-9.
Akenami, F. O., Aken'Ova, Y. A., & Osifo, B. O. (1999). Serum zinc, copper and magnesium in sickle cell disease at Ibadan, south western Nigeria. African Journal of Medicine and Medical Sciences, 28(3-4), 137-9.
Akenami FO, Aken'Ova YA, Osifo BO. Serum Zinc, Copper and Magnesium in Sickle Cell Disease at Ibadan, South Western Nigeria. Afr J Med Med Sci. 1999;28(3-4):137-9. PubMed PMID: 11205817.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Serum zinc, copper and magnesium in sickle cell disease at Ibadan, south western Nigeria. AU - Akenami,F O, AU - Aken'Ova,Y A, AU - Osifo,B O, PY - 2001/2/24/pubmed PY - 2001/4/3/medline PY - 2001/2/24/entrez SP - 137 EP - 9 JF - African journal of medicine and medical sciences JO - Afr J Med Med Sci VL - 28 IS - 3-4 N2 - Serum zinc, copper and magnesium were studied in patients with sickle cell disease in the steady state. There was significantly lower serum zinc concentration (P < 0.01) and significantly higher serum copper and magnesium in haemoglobin S patients compared with controls (HbA). In haemoglobin SC patients, there was a significant reduction in serum zinc (P < 0.01) but no significant difference in serum copper and magnesium concentrations compared with the controls. There was no significant difference in serum zinc concentration between the HbS and HbS + C patients. However there were significantly higher serum copper and magnesium in HbS than HbS + C patients (P < 0.01) The level of serum zinc has no correlation with the steady state Haematocrit or severity index score in HbS and HbS + C patients. SN - 0309-3913 UR - https://www.unboundmedicine.com/medline/citation/11205817/Serum_zinc_copper_and_magnesium_in_sickle_cell_disease_at_Ibadan_south_western_Nigeria_ L2 - http://www.diseaseinfosearch.org/result/6589 DB - PRIME DP - Unbound Medicine ER -